Doxifluridine combined with weekly paclitaxel for second-line treatment in patients with gastric cancer resistant to TS-1

International Journal of Clinical Oncology

Volumn 12, Issue 2, 2007, Pages 146-149

  Arai, Wataru ^a   Hosoya, Yoshinori ^a   Hyodo, Masanobu ^a   Haruta, Hidenori ^a   Kurashina, Kentaro ^a   Saito, Shin ^a   Hirashima, Yuuki ^a   Yokoyama, Taku ^a   Zuiki, Toru ^a   Sakuma, Kazuya ^a   Yasuda, Yoshikazu ^a   Nagai, Hideo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Doxifluridine; Gastric cancer; Second line chemotherapy; TS 1 failure; Weekly paclitaxel

Indexed keywords

ANTINEOPLASTIC AGENT; DEXAMETHASONE; DEXCHLORPHENIRAMINE MALEATE; DOXIFLURIDINE; FLUTULON; GRANISETRON; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL; RANITIDINE; TS 1; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER RESISTANCE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG FEVER; DRUG RESPONSE; FATIGUE; FEMALE; HEART ARRHYTHMIA; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PILOT STUDY; PLEURA EFFUSION; PRIORITY JOURNAL; SIDE EFFECT; STOMACH CANCER; TASTE DISORDER;

ABDOMINAL NEOPLASMS; ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOXURIDINE; HUMANS; JAPAN; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; PILOT PROJECTS; SILICATES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; TITANIUM; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 34247346943     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-006-0642-x     Document Type: Article

References (27)

1. Y Sakata A Ohtsu N Horikoshi 1998 Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients Eur J Cancer 34 1715 1720
2. W Koizumi M Kurihara S Nakano 2000 Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group Oncology 58 191 197
3. A Ohtsu N Boku F Tamura 1998 An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer Am J Clin Oncol 21 416 419
4. Y Yamada K Shirao A Ohtsu 2001 Phase II trial of paclitaxel by 3-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions Ann Oncol 12 1133 1137
5. K Yamaguchi M Tada N Horikoshi 2002 Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer Gastric Cancer 5 90 95
6. AD Seidman CA Hudis J Albanel 1998 Dose dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer J Clin Oncol 16 3353 3361
7. NR Abu-Rustum C Aghajanian RR Barakat 1997 Salvage weekly paclitaxel in recurrent ovarian cancer Semin Oncol 24 5 Suppl 15 S15-62 S15-67
8. AY Chang J Rubis R Asbury 2001 Weekly paclitaxel in advanced non-small cell lung cancer Semin Oncol 28 10 13
9. N Sawada T Ishikawa Y Fukase 1998 Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts Clin Cancer Res 4 1013 1019
10. T Moriwaki I Hyodo T Nishina 2005 A phase I study of doxifluridine combined with weekly paclitaxel for metastatic gastric cancer Cancer Chemother Pharmacol 56 138 144
11. I Takeyoshi F Makita Y Tanahashi 2005 A combination phase I study of weekly paclitaxel and doxifluridine in advanced gastric cancer patients Anticancer Res 25 1291 1296
12. N Saijyo K Kubota K Tobinai 1999 National Cancer Institute - Common Toxicity Criteria (NCI-CTC version 2.0) - Japan Clinical Oncology Group Jpn J Cancer Chemother 26 8 1084 1144
13. P Therasse SG Arbuck EA Eisenhauer 2000 New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 205 216
14. AM Murad FF Santiago A Petroianu 1993 Modified therapy with 5-fluor-ouracil, doxorubicin, and methotrexate in advanced gastric cancer Cancer 72 37 41
15. B Glimelius K Hoffman U Haglund 1994 Initial or delayed chemotherapy with best supportive care in advanced gastric cancer Ann Oncol 5 189 190
16. S Pyrhonen T Kuitunen P Nyandoto 1995 Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer Br J Cancer 71 587 591
17. W Koizumi S Tanabe K Saigenji 2003 Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer Br J Cancer 89 2207 2212
18. I Kokufu T Tanei H Taniguchi 2002 A case of effective weekly paclitaxel administration for metastatic gastric cancer Jpn J Cancer Chemother 29 2005 2008
19. Y Fujiwara S Tamura S Yoshioka 2002 Three case of advanced and recurrent gastric cancer treated with paclitaxel after TS-1 administration Jpn J Cancer Chemother 29 2555 2559
20. T Suzuki M Iwabuchi Y Matsuda 2003 Treatment outcomes with paclitaxel for advanced gastric cancer patients previously treated with TS-1 Jpn J Cancer Chemother 30 133 139
21. S Hironaka S Zenda N Boku 2006 Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer Gastric Cancer 9 14 18
22. AF Cook MJ Holman MJ Kramer 1979 Fluorinated pyrimidine nucleosides. 3. Synthesis and antitumor activity of a series of a 5′-deoxy-5- fluoropyrimidine nucleosides J Med Chem 22 1330 1335
23. H Ishitsuka M Miwa K Takemoto 1980 Role of uridine phosphorylase for antitumor activity of 5′-deoxy-5-fluorouridine Gann 71 23 34
24. M Miwa M Ura M Nishida 1998 Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue Eur J Cancer 34 1274 1281
25. T Ishikawa F Sekiguchi Y Fukase 1998 Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts Cancer Res 58 685 690
26. I Takeyoshi K Iwanami T Yamada 2005 Advanced gastric cancer with peritoneal dissemination successfully treated with paclitaxel and doxifluridine: a case report Hepatogastroenterology 52 322 325
27. TM Loffler W Freund J Lipke TU Hausamen 1996 Schedule- and dose-intensified paclitaxel as weekly 1-hour infusion in pretreated solid tumors: results of a phase I/II trial Semin Oncol 23 6 Suppl 16 32 34